A surprising investor: the outstanding player in the NBA joins an Israeli company as a brand ambassador
The Israeli startup company Antidote, which works to make medical services accessible at attractive costs to the population without sufficient insurance coverage in the US, announced that Yanis Antetokounmpo will invest and serve as the brand's ambassador: "Proud to lead with him the way he creates a legacy"
Wednesday, August 10, 2022, 3:00 p.m
Share on Facebook
Share on WhatsApp
Share on Twitter
Share by email
Share in general
The Israeli startup company Antidote, which works to make medical services accessible at attractive costs to the population without insurance coverage or those who are underinsured in the US, announced today (Wednesday) its new brand ambassador,
Yannis Antetokounmpo, a star of the NBA's Milwaukee Bucks and one One
of the best basketball players in the world
Antetokounmpo, who was born and raised in Greece to parents who immigrated from Nigeria, is known as the "Greek Freak", due to his origin and his unique basketball skill set. Antetokounmpo, who along with his family experienced the difficulty in receiving medical services, believes in the values of compassion and will be a significant voice Antidote's vision is to use innovation to leave no one behind without medical services, which is a basic human right.
"I believe that every person has the right to quality medical services at an affordable price, regardless of their circumstances, race, or location, and therefore I am proud to join forces with Antidote," said Yanis.
"My siblings and I grew up on the margins, with nothing. Although we had the support of a loving pair of parents, getting medical services was a challenging and difficult thing for us. Therefore, I feel a deep empathy with so many Americans who cannot achieve their dreams, due to hardship in receiving medical treatments. An antidote can help solve this crisis."
Not only a legendary actor, but also a significant figure.
Giannis Antetokounmpo (Photo: Reuters)
In the United States, one of the most developed countries in the world, nearly 30 million citizens under the age of 65 are uninsured, according to the latest updated data from the CDC. Another study indicates that more than a third of Americans - insured or uninsured - will not be able to pay for care In addition, although the US spends more on health care than any other country, the average American life expectancy is lower than in other developed countries.
This is an injustice that is not only bad for the economy and is a burden on the health system, but also constitutes a moral defect.
Beyond his role as Antidote's brand ambassador, Yanis also joins as an investor in the company, with the understanding that the capital will help the community, including his own in Milwaukee, Wisconsin, and that the expansion of Antidote's capabilities will lead to accessible medical services for more and more communities and people.
Antetocompo hopes to strengthen the vision of Antidote and help to implement it, to make medical services accessible to everyone, and especially for those who have difficulty obtaining them.
"While sports fans see Yannis as a legendary player who recently received the largest contract in the history of professional sports, he has another significant side, one that tells the difficulty he and his family experienced as immigrants in a country far from their homeland," says
Avihai Sodri, co-founder and CEO Antidote
"Iannis has a big heart full of compassion.
He understands the difficulties and obstacles on the way to accessible medical services, and how careful physical and mental health can be the difference between suffering and joy, failure or success.
We are proud and fortunate to have Yannis join our court, and to lead with him the way in which he creates a legacy that goes far beyond the world of basketball."
Ben Anush, co-founder and president of Antidote
, tells about the move that led to Yannis joining: "Welltech Ventures, who are among our investors, literally sat on the fence and acted with determination to allow this thing to happen. Welltech were the ones who recognized the fit between Antidote and Yannis, initiated the move, And use the best abilities and connections so that this will take off. When talking about added value that you want to receive from your investors, this is an excellent example of such a thing."
Amir Elroy and Galit Horowitz, partners in Welltech
, added: "Antidot realizes a very important vision for human society, of making quality medicine accessible to everyone through technology. The investment in it reflects the principles of Welltech Ventures' activity to promote technologies that benefit people's well-being and health, and we are excited about the continuation of the work With Antidote's leading team, all the more so after Yannis joined the company's important mission."
A huge star who goes beyond his performance on the field, tells the story of the difficulties he and his family experienced as immigrants in a foreign land (Photo: GettyImages, Maddie Meyer)
Antidote was founded in 2020 by the company's CEO Avihai Soderi, VP of Technologies Karin-Bel Feder, VP of Medicine David Zlotnik and the company's president Ben Anoush. The company, whose motto is providing medical services to everyone, operates an application based on artificial intelligence that enables Receiving treatments from a distance (tele-health) ranging from emergency treatments to mental health.
Antidote's service operates around the clock, 24/7, and today the company offers its services in approximately 22 US states, and serves populations without medical insurance or those who are underinsured - A population estimated at about 42 million inhabitants.
Antidote has actually adopted the model of the Israeli health insurance fund, according to which it is both the treating entity and the insuring entity, thus creating uniformity of interests.
The company employs over 300 doctors who provide services via video, and if necessary refers to clinics for physical treatments.
Antidote provides its customers, who can choose between a fixed monthly subscription and an annual subscription, a card through which they can purchase medicines at affordable costs in pharmacies in their area of residence.
Advertising and media